Tech Company Financing Transactions
Synthego Funding Round
On 10/23/2017, Synthego raised funding from Intel Capital.
Transaction Overview
Company Name
Announced On
10/23/2017
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Intel Capital (Wendell Brooks)
Proceeds Purpose
We are excited to invest in the Synthego team, and we look forward to the life changing breakthroughs a data-oriented view can deliver to medical researchers.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3696 Haven Ave.
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Overview
Synthego is a genome engineering company that enables the acceleration of life science research and development in the pursuit of improved human health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Dabrowski
Browse more venture capital transactions:
Prev: 10/23/2017: Constructor.io venture capital transaction
Next: 10/23/2017: Honcker venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs